3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow siponimod: new trials by email Literature Review of siponimod trials Research Report on siponimod
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function BAF312 - Renal Impairment | Phase 1 | Completed | Novartis Pharmaceuticals | 16 | 2013-07-01 | 2020-12-08 |
| Pharmacokinetics of BAF312 in Patients With Hepatic Impairment BAF312 - Hepatic Impairment | Phase 1 | Completed | Novartis Pharmaceuticals | 40 | 2012-10-01 | 2020-12-29 |
| Single Dose Study to Assess the Safety, Tolerability, Concentration in Body and Effect of BAF312 BAF 312 - Healthy | Phase 1 | Completed | Novartis | 63 | 2006-10-01 | 2007-11-29 |
Novartis Pharmaceuticals (2) · Novartis (1)
United States (2) · Hungary (1) · Romania (1) · Russia (1)